Lexaria Bioscience Corp. — Investor Relations & Filings
Filings indexed
1,010
across all filing types
Latest filing
2026-04-13
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
LEXX
Lexaria Bioscience Corp. is a biotechnology company focused on the development and commercialization of its patented drug delivery platform, DehydraTECH™. This technology is designed to improve the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral administration. DehydraTECH™ enhances the bioavailability of APIs, which can enable faster absorption, increased efficacy, and the potential for reduced drug dosages. The company operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with numerous patents granted globally for its platform technology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Lexaria Bioscience Corp. (0001348362) (Filer) | 2026-04-13 | English | |
| 4 - Lexaria Bioscience Corp. (0001348362) (Issuer) | 2026-03-18 | English | |
| 8-K Filing | 2026-02-06 | English | |
| S-8 Filing | 2026-01-28 | English | |
| 8-K Filing | 2026-01-28 | English | |
| 25-NSE Filing | 2026-01-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 34424401 | 10-Q - Lexaria Bioscience Corp. (0001348362) (Filer) | 2026-04-13 | English | ||
| 32976920 | 4 - Lexaria Bioscience Corp. (0001348362) (Issuer) | 2026-03-18 | English | ||
| 29022250 | 8-K Filing | 2026-02-06 | English | ||
| 29022322 | S-8 Filing | 2026-01-28 | English | ||
| 29022316 | 8-K Filing | 2026-01-28 | English | ||
| 29022352 | 25-NSE Filing | 2026-01-14 | English | ||
| 29022243 | 424B3 Filing | 2026-01-14 | English | ||
| 29022297 | 10-Q Filing | 2026-01-13 | English | ||
|
2025
7 filings
| |||||
| 11930106 | FORM S-1 | 2025-12-29 | English | ||
| 11930109 | Regulatory Filings 2025 | 2025-12-19 | English | ||
| 11930112 | FORM 8-K | 2025-12-16 | English | ||
| 11930113 | 424B5 | 2025-12-16 | English | ||
| 11930117 | FORM DEF 14A | 2025-12-10 | English | ||
| 11930115 | Regulatory Filings 2025 | 2025-12-10 | English | ||
| 11930118 | 424B3 | 2025-12-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AnorMED Inc.
Developed small molecule therapeutics for serious diseases,…
|
— | CA | Professional, scientific and te… |
|
ANTEOTECH LTD
Develops nanoglue technology for life sciences and lithium-…
|
ADO | AU | Professional, scientific and te… |
|
Anthem Biosciences Limited
Integrated CRAMS organization for drug discovery, developme…
|
ANTHEM | IN | Professional, scientific and te… |
|
APPLIED DNA SCIENCES INC
Develops and manufactures DNA-based technologies for geneti…
|
APDN | US | Professional, scientific and te… |
|
Aprea Therapeutics, Inc.
Clinical-stage biopharma developing cancer therapeutics via…
|
APRE | US | Professional, scientific and te… |
|
AprilBio Co.,Ltd.
Develops long-acting biologic drugs for autoimmune diseases…
|
397030 | KR | Professional, scientific and te… |
|
Aptahem AB
A clinical-stage biotech developing aptamer-based drugs for…
|
APTA | SE | Professional, scientific and te… |
|
APTAMER GROUP PLC
Develops custom affinity binders for research, diagnostics,…
|
APTA | GB | Professional, scientific and te… |
|
Aptevo Therapeutics Inc.
Clinical-stage biotech developing antibody-based immunother…
|
APVO | US | Professional, scientific and te… |
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
Lexaria Bioscience Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34983/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34983 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34983 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34983 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34983}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lexaria Bioscience Corp. (id: 34983)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.